Her A1C Was 8.4%. Her Family Blamed the Recipe Book.

The notebook had been in her kitchen for 23 years. Its recipes began with instructions from her mother, written down after phone calls: how long to soften onions for sofrito, when the rice had absorbed enough water, which parts of a pork shoulder needed another cut.

There were few measurements. Her mother cooked by sight. The daughter, a school cafeteria manager in New Jersey, translated handfuls into cups because the district kitchens where she had worked for 17 years required quantities that another person could repeat.

In November 2024, she wrote a different kind of number inside the back cover: A1C 8.4%.

The result had appeared in her patient portal after a routine visit. Under the number, the system marked it high. She knew A1C had something to do with blood sugar, but the page did not tell her why the value had risen from 6.4% in March 2023, or why no one had contacted her during the first two days after it appeared.

She waited through the weekend. On Monday, the primary care doctor’s office called and arranged a follow-up.

The years before 8.4%

Her first elevated A1C had been 6.1% in May 2021. The primary care doctor used the word prediabetes and said, “Watch the carbs.” She remembers that sentence because there was little attached to it: no conversation about her work schedule, no referral to a dietitian, and no plan she understood beyond another blood test the following year.

She left with a printed page about weight loss.

At work, she was responsible for meals served to hundreds of children, handling staffing gaps and food deliveries while spending much of the day close to food she had no time to sit down and eat. Some mornings she ate a piece of toast before leaving home. Lunch might be bites taken between tasks. Dinner was the meal she protected, usually shared with her husband and whichever relative had stopped by.

In August 2022, her A1C was 6.3%. Seven months later, it was 6.4%.

Each result brought a version of the same exchange about weight and carbohydrates, although diabetes ran through both sides of her family and her sleep had deteriorated during menopause. Those facts were entered into the record. They did not seem to change the conversation.

The next planned test slipped past her in 2024 while she was helping her father after an illness and covering vacancies at work. She did not receive another reminder that she remembers. Eighteen months passed between blood draws.

At the November follow-up, the primary care doctor reviewed the 8.4% result and another lab value, then said, “This is type 2 diabetes.” The doctor explained that A1C reflects average blood glucose over roughly the previous two to three months. It was not a score for the dinner she had eaten the night before.

That distinction mattered later. It did not make the diagnosis smaller.

She copied the number into the recipe notebook because it was the place where she kept information she expected to use again. Below it, she wrote the month and the words the doctor had used. Then she closed the book and made rice.

What the prescription seemed to prove

The first medication discussion focused on a common oral diabetes drug. Six weeks later, after another appointment and a review of her results, the doctor also raised a GLP-1 medication. The doctor described possible effects on blood glucose and appetite, along with gastrointestinal side effects and the limits of what insurance might cover.

She did not agree that day.

She had heard coworkers discuss the drugs as weight-loss injections, often with admiration followed by suspicion. Online, she found accounts of nausea, shortages and regained weight after stopping. At home, relatives had absorbed another message: if a doctor wanted her to inject a medication associated with weight loss, then the family’s food must have caused the problem.

Her younger sister said she should stop making arroz con gandules. An aunt pointed to the pernil served during the holidays. Another relative suggested throwing away the recipe notebook and starting over with meals from a diabetes website.

The certainty angered her more than the comments themselves. No one had blamed the hurried lunches at work, the years of elevated results without sustained support, or the family history that had once been treated as background information. They blamed rice because it was visible.

She set the notebook on the table and opened it to a beans recipe her mother had dictated more than two decades earlier. The ingredients were ordinary. The page also held evidence of change: less salt after her husband developed high blood pressure, a smaller batch after her children moved out, and a note about adding water when canned beans replaced dried ones on work nights.

The book had never been fixed.

Type 2 diabetes does not reduce to one family dish. The primary care doctor later described it as a condition shaped by several factors, including genetics and how the body responds to insulin over time. Food remained part of the discussion, but the prescription was not proof that Puerto Rican cooking had produced an A1C of 8.4%.

Still, she began to feel that she had to defend every plate. At a family dinner in January 2025, she served herself rice and beans, then noticed two relatives watching. She finished eating. Afterward, she wrote nothing in the notebook.

Seven weeks with the decision

Insurance delayed the GLP-1 decision without resolving it. The pharmacy initially quoted more than $900 for a month, an amount she would not pay. The doctor’s office submitted additional information, and she called the number on the back of her insurance card twice over the next three weeks.

The consequential detail was not the paperwork. It was the delay, which gave everyone around her time to develop an opinion while she still did not know whether the medication would be available at a price she could afford.

Her husband favored taking it. Her sister treated it as a last resort. She moved between those positions, sometimes within the same day, because she wanted her blood glucose lower and also wanted a clearer account of what would happen if nausea interfered with work in a cafeteria where stepping away was rarely easy.

A diabetes educator spent part of one visit with the recipe notebook open between them. They discussed what she ate on workdays and what she cooked when relatives came over, without treating those as the same circumstances. The educator did not cross out the rice or beans. Together they added quantities to two recipes so the daughter could understand how much she was serving herself, a change that felt practical rather than punitive.

She wrote “beans stay” in the margin.

Five weeks after the first insurance rejection, the pharmacy told her the medication had been approved with a $35 monthly cost. Approval settled the price. It did not settle whether she was ready.

She left the carton at the pharmacy for two more days, then picked it up and placed it in the refrigerator. That evening, she read the patient information while her husband washed dishes. She did not open the recipe notebook.

The following weekend, seven weeks after the doctor first proposed the GLP-1, she started it. The decision was quieter than the family argument had been. She had mild nausea during the first week and packed a smaller lunch because that was what felt manageable to her. She continued working.

There was no immediate transformation. Her next A1C test was still months away, and the medication did not answer why earlier warnings had produced so little help beyond instructions to watch carbohydrates. It also did not end the family commentary. At the next dinner, an aunt asked whether she was allowed to eat what she had cooked.

She said the doctor had not banned her food.

In February 2025, she returned to the notebook. Beside the arroz con gandules recipe, she recorded the amount that now fit the pot she used for dinner with her husband. She left her mother’s original instruction beneath it.

Both remained legible.

Questions people ask

Does an A1C of 8.4% mean type 2 diabetes?

In this composite story, the primary care doctor interpreted the 8.4% result with other lab information and the woman’s history before diagnosing type 2 diabetes. An A1C represents average blood glucose over about two to three months, so it was not treated as a verdict on one meal or one recipe.

Does starting a

GLP-1 mean traditional food caused diabetes?

No such conclusion followed from the prescription in this story. Her doctor described type 2 diabetes as involving multiple influences, including family history and the body’s response to insulin over time. Food was discussed, but the GLP-1 did not establish that Puerto Rican meals had caused her condition.

How long did the GLP-1 insurance decision take?

Five weeks passed between the initial rejection and approval at a $35 monthly cost. During that period, the doctor’s office sent additional information and she contacted the insurer twice. The approval answered the cost question, while her concerns about side effects at work remained.

What changed in her recipe book after the diagnosis?

She added quantities to two recipes so she could understand her own servings, while keeping the dishes and her mother’s original instructions. The back cover still held “A1C 8.4%,” and the beans page still held the note she wrote after meeting the educator: “beans stay.”